Lifescience Creations is a decision support and strategic insight consulting firm helping life sciences companies (pharmaceutical, biotechnology, diagnostics and medical devices) with strategic insight and foresight to improve their assumptions, enabling them to make better decisions both during a pre- and post-commercialisation of product(s) and/or therapeutic portfolios.
The core of our Medical Education (MedEd) and communmication (MedComm) expertise is to make healthcare professionals and patients aware of additional healthcare products and services within preventive and/or therapeutic pathways.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Avalere Health is a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Working from advisory to performance, we combine our knowledge and expertise across our disciplines…
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic Performance (ESP) in medical communications since 2007 through impactful strategy,…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes.
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.
We are Wizzard: an independently owned, fully-integrated medical communications agency that is committed to crafting brilliant and engaging work. We work alongside you to cultivate a deep understanding of your…
Company Details
Latest Content from PMHub
Videos and Podcasts | July 13, 2016 | Lucid Group Communications Limited
From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...
Videos and Podcasts | July 13, 2016 | Lucid Group Communications Limited
The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.
Press Releases | July 11, 2016 | Health Unlimited
Health Unlimited, Liberation Unlimited and Rock Unlimited all win the judges’ approval.
Press Releases | July 8, 2016 | Lucid Group Communications Limited
Lucid Group’s commitment to be a leader in medical education was recognised at the Communiqué Awards 2016 in London last night, where the agency received three awards, including being highly...
White Papers and Resources | July 6, 2016 | Anthill Agency
Your customer-facing staff continually gets told about the needs and wants of your customers. Are you learning what they are learning?
White Papers and Resources | July 6, 2016 | Inizio
Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...
White Papers and Resources | July 6, 2016 | Inizio
As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...
White Papers and Resources | July 6, 2016 | Inizio
Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST
White Papers and Resources | July 6, 2016 | Inizio
The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme. Technology...
White Papers and Resources | July 6, 2016 | Inizio
The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker...